Investing.com - DR Horton (NYSE: DHI) reported third quarter EPS of $4.10, $0.33 better than the analyst estimate of $3.77. Revenue for the quarter came in at $10B versus the consensus estimate of $9.64B.
Guidance
DR Horton sees FY 2024 revenue of $36.80B-$37.20B versus the analyst consensus of $36.96B.
DR Horton's stock price closed at $157.52. It is up 10.78% in the last 3 months and up 23.21% in the last 12 months.
DR Horton saw 3 positive EPS revisions and 12 negative EPS revisions in the last 90 days. See DR Horton's stock price’s past reactions to earnings here.
According to InvestingPro, DR Horton's Financial Health score is "great performance".
Check out DR Horton's recent earnings performance, and DR Horton's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar